Thorax · 1987 · 222 citations · 26 references
MedicinePharmacologyNeuropharmacologyPharmacodynamicsSensory PhysiologyBronchodilator TherapyNeuropeptide PharmacologyRespiratory MedicineRespiratory PathophysiologyRespiratory PharmacologyAirway ConductanceAsthma PathophysiologyInhaled AdministrationInhaled TherapiesPharmacodynamics Of Inhaled DrugsSmall Airway ResponseSpecific Airway ResistanceSubstance P Pharmacology
The neuropeptides substance P and neurokinin A are present in sensory airway nerves. Their effect on airway calibre was compared in six healthy non-smoking subjects and six asthmatic subjects. On separate days increasing concentrations (from 10(-9) to 10(-6) mol/ml) of each neuropeptide were administered by nebuliser and the airway response measured as change in specific airway conductance (sGaw). Substance P and neurokinin A caused no change in sGaw in the healthy subjects. Inhalation of substance P up to the highest concentration of 10(-6) mol/ml caused no change in sGaw in the asthmatic subjects. Neurokinin A, however, caused bronchoconstriction with a mean fall in sGaw of 48% (SEM 12%) after 5 x 10(-7) mol/ml. The onset of bronchoconstriction was rapid, but sGaw had returned to baseline values within one hour in all but one patient.
26
Nucleotide sequences of cloned cDNAs for two types of bovine brain substance P precursor
Hiroyuki Nawa, Tadaaki Hirose, Hideaki Takashima et al. · Nature · 1983 · 757 citations
Peter J. Barnes · The Lancet · 1986 · 670 citations
V. Erspamer · Trends in Neurosciences · 1981 · 473 citations